Banana-shaped survival curves of metastatic renal cell carcinoma treated with first-line immune-combinations, not just a matter of "palateau"

• Главные авторы: Sara Elena Rebuzzi (Автор), Giuseppe Fornarini (Автор), Alessio Signori (Автор), Pasquale Rescigno (Автор), Giuseppe Luigi Banna (Автор), Sebastiano Buti (Автор)
• Формат: ‌
• Опубликовано: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

ABSTRACTThe first-line therapy of metastatic renal cell carcinoma (mRCC) has revolutionized with the approval of immune checkpoint inhibitors (ICIs) in combination with or without tyrosine kinase inhibitors (TKIs). The choice among the many different immuno-combinations (ICI-ICI or ICI-TKI) is chall...